Bruce D. Perkins is Director at AMEDISYS INC (AMED). They have made 10 open-market trades across 2 companies since 2013, most recently 2025-08-14.
CIK 0001018659
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
8 open-market purchases totalling $1.5M since 2015, against 2 sales. Across 8 scored buys the stock is up 7.8% at ninety days, and 0.8 points ahead of the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 88% | 100% | 63% |
| Avg Move | +6.4% | +13.5% | +7.8% |
| Alpha | +6.2% | +10.2% | +0.8% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AMED | SELL | 2021-09-01 | 2021-09-03 | $183.00 | $2.1M | -7.3% | -21.6% | -22.3% |
| AMED | BUY | 2021-03-01 | 2021-03-03 | $259.38 | $259K | +11.2% | +12.6% | +6.0% |
| AMED | BUY | 2020-06-12 | 2020-06-16 | $167.48 | $335K | +13.8% | +16.5% | +31.2% |
| AMED | BUY | 2020-03-12 | 2020-03-16 | $153.16 | $306K | +18.9% | +46.9% | +25.5% |
| AMED | BUY | 2019-05-15 | 2019-05-17 | $111.84 | $280K | +3.9% | +10.6% | +20.1% |
| AMED | BUY | 2017-08-02 | 2017-08-03 | $46.60 | $93K | +4.1% | +10.6% | -2.0% |
| AMED | BUY | 2017-05-25 | 2017-05-26 | $59.69 | $30K | +5.2% | +9.7% | -17.1% |
| AMED | BUY | 2016-05-13 | 2016-05-17 | $50.21 | $50K | +0.6% | +0.2% | -2.2% |
| AMED | BUY | 2015-07-31 | 2015-07-31 | $43.07 | $129K | -6.2% | +0.9% | +0.9% |
| HUM | SELL | 2013-08-13 | 2013-08-14 | $93.47 | $841K | -7.8% | +1.2% | +1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.